AbbVie to invest $380 million to expand US manufacturing in Illinois

Core Viewpoint - AbbVie announced a $380 million investment to construct two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, aimed at enhancing domestic production capacity for its products [1] Group 1: Company Investment - The investment of $380 million will be directed towards building two new manufacturing facilities [1] - The new facilities will focus on the production of active pharmaceutical ingredients [1] - This expansion is part of AbbVie's strategy to increase its domestic production capabilities [1] Group 2: Industry Impact - The investment reflects a broader trend in the pharmaceutical industry towards increasing domestic manufacturing capacity [1] - Enhancing local production capabilities may lead to improved supply chain resilience within the industry [1]